SOUTH SAN FRANCISCO, Calif. (AP) _ NGM Biopharmaceuticals Inc. (NGM) on Thursday reported a loss of $36.7 million in its second quarter.

The South San Francisco, California-based company said it had a loss of 48 cents per share.

The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.

The biotechnology company posted revenue of $16.8 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $22.1 million.

NGM Biopharmaceuticals shares have decreased 24% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $23.04, an increase of 20% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NGM at https://www.zacks.com/ap/NGM

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News